14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Wednesday, 24th Apr 2024 AXSM stock ended at $71.17. This is 2.61% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.61% from a day low at $69.92 to a day high of $73.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Feb 18, 2021 $71.30 $72.28 $70.01 $71.18 330 336
Feb 17, 2021 $73.94 $74.24 $71.38 $72.02 281 042
Feb 16, 2021 $75.25 $75.86 $74.10 $74.71 243 309
Feb 12, 2021 $73.75 $74.94 $72.03 $74.63 275 098
Feb 11, 2021 $75.76 $75.85 $73.18 $73.70 194 065
Feb 10, 2021 $75.51 $76.48 $72.40 $75.00 176 822
Feb 09, 2021 $75.36 $77.08 $74.95 $75.05 215 348
Feb 08, 2021 $76.15 $77.25 $74.71 $75.27 246 455
Feb 05, 2021 $76.54 $76.62 $73.95 $75.25 216 482
Feb 04, 2021 $75.93 $78.00 $75.00 $75.88 298 475
Feb 03, 2021 $73.90 $75.64 $73.53 $75.53 215 638
Feb 02, 2021 $72.00 $73.99 $71.94 $73.73 251 382
Feb 01, 2021 $69.50 $71.99 $68.29 $70.89 423 385
Jan 29, 2021 $69.97 $70.48 $67.67 $68.09 332 507
Jan 28, 2021 $70.08 $71.38 $68.90 $69.84 501 136
Jan 27, 2021 $72.03 $72.12 $68.61 $69.17 605 705
Jan 26, 2021 $76.03 $76.92 $72.89 $72.99 299 521
Jan 25, 2021 $75.06 $75.67 $72.36 $75.56 349 853
Jan 22, 2021 $75.19 $75.99 $74.56 $74.65 243 526
Jan 21, 2021 $76.23 $77.05 $74.39 $75.90 250 556
Jan 20, 2021 $76.88 $77.12 $75.20 $75.92 174 559
Jan 19, 2021 $77.97 $78.35 $76.58 $76.96 241 555
Jan 15, 2021 $79.82 $80.42 $76.42 $76.75 229 099
Jan 14, 2021 $80.14 $81.25 $79.22 $79.89 154 876
Jan 13, 2021 $80.00 $82.87 $78.92 $79.50 289 087
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT